Kreatech Diagnostics (Netherlands) a commercial-stage molecular diagnostics company focused on DNA FISH probes and nucleic acid labeling technologies, closed a $2.7M Series B financing. Participants include Alafi Capital and Life Science Partners.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb